Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
President & CEO
Ronan O’Hagan, President & CEO, Bectas Therapeutics Inc.
Rónán O’Hagan is a founder and the President and Chief Executive Officer for Bectas Therapeutics Inc. He has over 20 years of experience in oncology R&D including bringing over 20 molecules through IND and into clinical development and helping to guide 4 drugs through clinical development to FDA approval. Ronan is also the CSO at Apricity Health and was formerly the CSO at Xilio therapeutics where he built the R&D and Business Development teams from scratch, developed the protein engineering platform, and brought two programs through IND filings and two more to clinical candidate stage within three years. Ronan helped the Xilio team to raise over $250M in private financings and to an IPO. Previously, Ronan led Oncology Discovery and co-led Translational Oncology for Merck (MSD) supporting the R&D pipeline through leadership of discovery, translational, early clinical development and business development teams. Earlier, he was also the first scientist at AVEO Pharmaceuticals, Inc, with responsibility for developing the research portfolio and he rose through positions of increasing responsibility as the company moved from discovery into clinical development and grew from start-up stage through IPO.